Results of 62005 study available now

SPAEN Study Results 62005 04







The 62005 study looked at the ten-year progression-free and overall survival in patients with unresectable or metastatic gastrointestinal stromal tumours (GIST). Long-term analysis of the EORTC, ISG, AGITG intergroup Phase III randomized trial on imatinib at two dose levels.

Results Study 62005

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.